1/9
06:10 am
anab
AnaptysBio (NASDAQ:ANAB) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
AnaptysBio (NASDAQ:ANAB) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
03:36 pm
anab
Rating for ANAB
Medium
Report
Rating for ANAB
12/18
09:09 am
anab
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/18
09:09 am
anab
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/17
12:31 pm
anab
Rating for ANAB
Low
Report
Rating for ANAB
12/17
12:31 pm
anab
Rating for ANAB
Low
Report
Rating for ANAB
12/17
06:02 am
anab
AnaptysBio (NASDAQ:ANAB) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/11
08:16 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/24
08:43 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
11/24
08:43 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
11/24
08:21 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
11/24
08:21 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
11/11
09:54 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/11
09:54 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/10
02:04 pm
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
11/10
02:04 pm
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
11/5
10:06 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/5
10:06 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/5
09:55 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/5
09:55 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
10/29
12:51 pm
anab
Rating for ANAB
Medium
Report
Rating for ANAB
10/15
11:10 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
10/15
11:10 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB